Hydrogel-based Drug Delivery System Market Size, Share & Trends Analysis Report By Polymer Origin (Natural, Synthetic, Hybrid), By Route (Subcutaneous, Ocular, Oral Cavity)- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2021-2027
The global Hydrogel-based Drug Delivery System market gathered revenue around USD 6.1 Billion in 2020 and market is set to grow USD 11.4 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 8.0% during the prediction period 2021 to 2027.
The market Hydrogels help in achieving spatial and temporal control over the release of the incorporated drug. Therefore, the surging demand for controlled releases drug delivery system across many therapeutic areas is a key factor expected to contribute to market growth during the forecast period.
Hydrogel-based drug delivery systems deliver the therapeutic drug directly at the target site and in a sustained manner. This can leverage beneficial outcomes such as improved efficacy, reduced side effects, and decreased dosage for patients and formulators. Hydrogel-based drug delivery systems are appealing and have been used in many branches of medicine such as oncology, pain management, immunology, cardiology, and wound management.
The unique physical properties of hydrogel attract their interest in use for drug delivery applications. The porosity and drug loading capacity of hydrogels can be adjusted by modifying the density of cross-linking. This helps them to protect liable large drug molecules from degradation increasing the half-life. Many research studies have been carried out to examining the delivery of insulin orally using hydrogel systems. As patient compliance issues are frequently reported with injectable insulins such innovation is expected to be a disruptive technology in the diabetes care market.
There are numerous clinical studies underway specific to hydrogel-based drug delivery systems and various hydrogel technologies have already received regulatory approval for biomedical application. However, the technological challenges including the absence of defined regulatory guidelines, chemistry, complex manufacturing and control paraments, and practical adaptability are major roadblocks in the successful implementation in drug delivery use. For instance, the fabrication of hydrogel is complex and varies significantly depending upon the hydrogel systems.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Hydrogel-based Drug Delivery System market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Hydrogel-based Drug Delivery System market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
|Market Size||USD 11.4 Billion by 2027|
|Growth Rate||CAR 8.0% From 2021 to 2027|
|Forecast Period||2021 to 2027|
|Largest Market||North America|
|Fastest Growing Market||Asia Pacific|
|Segments Covered||Polymer origin, delivery route and Region|
|Report coverage||Growth Factors, Revenue Status, Competitive Landscape, and Future Trends|
|Companies Mentioned||GALDERMA; Blairex Laboratories, Inc.; Johnson & Johnson; Bausch and Lomb; Medtronic; Ocular Therapeutix, Inc.; Ferring B.V.; Endo International plc; Akorn, Incorporated; Tolmar Pharmaceuticals, Inc.|
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Hydrogel-based Drug Delivery System market Report empowers readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
North America dominated the hydrogel-based drug delivery systems market and accounted for the largest revenue share of 47.1% in 2020. The presence of efficient reimbursement that covers the cost of modern therapies, the domicile presence of hydrogel suppliers, and frequent product launches are the key factors expected to contribute to market growth in the region. For instance, in Dec 2020, Dare Bioscience, a U.S.-based biopharmaceutical company announces positive results from clinical trials conducted to access the delivery of drugs (clindamycin phosphate 2%) using bioadhesive hydrogel in the treatment of bacterial vaginosis. Over 20 million people suffer bacterial vaginosis in the U.S.
Increasing the number of studies to optimize hydrogel-based protein delivery, increasing the prevalence of CNS disorders, and increasing funding in hydrogel-based drug delivery systems are the factors expected to propel market growth. In 2021 European Union announced funding for 13 projects including the development of a hyaluronan-based hydrogel system in mucosal drug delivery. The project is anticipated to commence in Oct 2021 and to continue over a period of three years. Such initiatives are anticipated to bring new hydrogel-based drug delivery systems, thereby propelling the market growth.
In Asia Pacific, the market for hydrogel-based drug delivery systems is expected to experience the fastest growth rate over the forecast period. The presence of a large target population, improving access to healthcare, surging demand for better medical care in many therapeutic areas, and rising demand to cut healthcare costs are the factors anticipated to drive the market growth over the forecast period. China, India, and South Korea are a few of the noticeable markets exhibiting lucrative growth rates in this region.
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
- Company Overview
- Company Market Share/Positioning Analysis
- Product Offerings
- Financial Performance
- Recent Initiatives
- Key Strategies Adopted by Players
- Vendor Landscape
- List of Suppliers
- List of Buyers
Some of the prominent players in the Hydrogel-based Drug Delivery System Market include: GALDERMA; Blairex Laboratories, Inc.; Johnson & Johnson; Bausch and Lomb; Medtronic; Ocular Therapeutix, Inc.; Ferring B.V.; Endo International plc; Akorn, Incorporated; Tolmar Pharmaceuticals, Inc.
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
- By Polymer Origin
- By Delivery Route
- Oral Cavity
- United Kingdom
- Rest of Europe
- Southeast Asia
- Rest of Asia Pacific
- Rest of Latin America
Middle East & Africa (MEA)
- North Africa
- South Africa
- Rest of Middle East & Africa
Highlights of the Report:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the market.
- Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market
- Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the market
In the study, a unique research methodology is utilized to conduct extensive research on the growth of the Hydrogel-based Drug Delivery System market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the Hydrogel-based Drug Delivery System market study are as follows - statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes the projections on the growth prospects of the Hydrogel-based Drug Delivery System markets more accurate and reliable.
It involves company databases such as Hoover's: This assists us recognize financial information, structure of the market participants and industry competitive landscape.
The secondary research sources referred in the process are as follows:
- Governmental bodies, and organizations creating economic policies
- National and international social welfare institutions
- Company websites, financial reports and SEC filings, broker and investor reports
- Related patent and regulatory databases
- Statistical databases and market reports
- Corporate Presentations, news, press release, and specification sheet of Manufacturers
Primary research includes face-to face interviews, online surveys, and telephonic interviews.
- Means of primary research: Email interactions, telephonic discussions and Questionnaire based research etc.
- In order to validate our research findings and analysis we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.
Industry participants involved in this research study include:
- CEOs, VPs, market intelligence managers
- Procuring and national sales managers technical personnel, distributors and resellers
- Research analysts and key opinion leaders from various domains
Key Points Covered in Hydrogel-based Drug Delivery System market Study:
- Growth of Hydrogel-based Drug Delivery System in 2021
- Market Estimates and Forecasts (2017-2027)
- Brand Share and Market Share Analysis
- Key Drivers and Restraints Shaping Market Growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Recommendation on Key Winning Strategies
- COVID-19 Impact on Demand for Hydrogel-based Drug Delivery System and How to Navigate
- Key Product Innovations and Regulatory Climate
- Hydrogel-based Drug Delivery System Consumption Analysis
- Hydrogel-based Drug Delivery System Production Analysis
- Hydrogel-based Drug Delivery System and Management